Secular trends in coronary heart disease mortality in Norway, 1966-1986

American Journal of Epidemiology

Volumn 137, Issue 3, 1993, Pages 301-310

  Sverre, Jan Marcus ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cohort studies; Coronary disease; Mortality; Poisson distribution; Risk factors

Indexed keywords

HEART DISEASE; MEDICAL GEOGRAPHY; MORTALITY RATE; POISSON DISTRIBUTION; SECULAR TREND; TIME-SERIES ANALYSIS;

NORWAY;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; FEMALE; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; PRIORITY JOURNAL;

AGE FACTORS; BIOLOGY; CAUSES OF DEATH; COHORT ANALYSIS; DELIVERY OF HEALTH CARE; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; EUROPE; HEALTH; HEALTH SERVICES; HEART DISEASES; MORTALITY; NORTHERN EUROPE; NORWAY; PERIOD ANALYSIS; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; RESEARCH METHODOLOGY; RISK FACTORS; SCANDINAVIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT EFFECT; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGE; MORTALITY; NORWAY; POPULATION SURVEILLANCE; PRIMARY PREVENTION; REGRESSION ANALYSIS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0027330495     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a116677     Document Type: Article

References (50)

1. Thom JT. International mortality from heart dis-ease: rates and trends. Int J Epidemiol 1989; 18(suppl. 1):S20-8.
2. Pisa Z, Uemura K. Trends of mortality from is-chaemic heart disease and other cardiovascular dis-eases in 27 countries, 1968-1977. World Health Stat 1982;35:11-49.
3. Thom JT, Epstein FH, Feldman JJ, et al. Trends in total mortality and mortality from heart disease in 26 countries from 1950 to 1978. Int J Epidemiol 1985;14:510-20.
4. Higgins M, Thom T. Trends in CHD in the United States. Int J Epidemiol 1989; 18(suppl. 1):S58-66.
5. Greiser E, Joeckel KH, Giersiepen K, et al. Cardio-vascular disease risk factors, CHD morbidity and mortality in the Federal Republic of Germany. Int J Epidemiol 1989; 18(suppl. 1):S 118-24.
6. Tuomilehto J, Puska P, Korhonen H, et al. Trends and determinants of ischaemic heart disease mor-tality in Finland: with special reference to a possible levelling off in the early 1980s. Int J Epidemiol 1989; 18(suppl. 1):S109-17.
7. Wilhelmsen L, Johansson S, Ulvenstam G, et al. CHD in Sweden: mortality, incidence and risk factors over 20 years in Gothenburg. Int J Epide-miol 1989; 18(suppl. l):S101-8.
8. Menotti A. Trends in CHD in Italy. Int J Epidemiol 1989; 18(suppl. 1):S 125-8.
9. Deev AD, Oganov RG. Trends and determinants of cardiovascular mortality in the Soviet Union. Int J Epidemiol 1989; 18(suppl. 1):S 137-44.
10. Beaglehole R, Dobson A, Hobbs MST, et al. CHD in Australia and New Zealand. Int J Epidemiol 1989; 18(suppl. 1):S 145-8.
11. Central Bureau of Statistics of Norway. Health statistics, 1985. Table 69. Oslo, Norway, 1987:108-13.
12. Standard classification of diseases, accidents, causes of death. 2nd ed. Oslo, Norway: Central Bureau of Statistics of Norway, 1973.
13. Baker RJ, Nelder JA. GLIM-Generalised linear interactive modelling. London, England: Royal Statistical Society, 1978.
14. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983;39: 311-24.
15. Kupper L, Janis JM, Karmous A, et al. Statistical age-period-cohort analysis: a review and critique. J Chronic Dis 1985;38:811-30.
16. Levi F, La Vecchia C, Decarli A. Effects of age, birth cohort and period of death on Swiss cancer mortality, 1951-1984. Int J Cancer 1987;40: 439-49.
17. Clayton D, Schifflers E. Models for temporal vari-ations in cancer rates. 1. Age-period and age-cohort models. Stat Med 1987;6:449-67.
18. Clayton D, Schifflers E. Models for temporal vari-ations in cancer rates. 2. The age-period-cohort model. Stat Med 1987;6:469-81.
19. Sverre JM, Laake P. Explaining trends in mortality for the aging population in Norway: a model with age, period and cohort effects. Epidemiology 1991; 3:182-7.
20. Rose G. Causes of the trends and variations in CHD mortality in different countries. Int J Epide-miol 1989; 18(suppl.l):S 174-9.
21. Stamler J. Opportunities and pitfalls in interna-tional comparisons related to patterns, trends and determinants of CHD mortality. Int J Epidemiol 1989; 18(suppl. 1):3-18.
22. Levy RI. The decline in cardiovascular disease mortality. Ann Rev Public Health 1981;2:49-70.
23. Thompson PL, Hobbs MS, Martin CA. The rise and fall of ischaemic heart disease in Australia. Aust N Z J Med 1988;18:327-37.
24. Pyörälä K, Salonen JT, Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology 1985;72: 35-51.
25. McBean LD, Speckmann EW. An interpretive re-view: diet in early life and the prevention of athero-sclerosis. Pediatr Res 1974;8:837-42.
26. Holman RL, McGill HC, Strong JP, et al. The natural history of atherosclerosis. The early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol 1958;34:209-35.
27. Ishii T, Hosoda Y, Tsugane S, et al. Natural history of aortic and coronary atherosclerosis in Tokyo. Mod Pathol 1988;1:205-11.
28. Lemer DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90.
29. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990;12:287-98.
30. Skouby SO, Andersen O, Petersen KR. Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level. Am J Obstet Gy-necol 1990;163:343-8.
31. Lynch WD, Glass GV, Tran ZV. Diet, tobacco, alcohol and stress as causes of coronary artery heart disease: an ecological trend analysis of national data. Yale J Biol Med 1988;61:413-26.
32. Blackburn H. Trends and determinants of CHD mortality: changes in risk factors and their effects. Int J Epidemiol 1989;18(suppl. 1):S210-15.
33. Menotti A, Keys A, Kromhout D, et al. Twenty-five-year mortality from coronary heart disease and its prediction in five cohorts of middle-aged men in Finland, the Netherlands and Italy. Prev Med 1990;19:270-8.
34. Reed D, Maclean C. The nineteen-year trends in CHD in the Honolulu Heart Program. Int J Epi-demiol 1989; 18(suppl. l):S82-7.
35. Aronow WS, Herzig AH, Etienne F, et al. 41-month follow-up of risk factors correlated with new coronary events in 708 elderly patients. J Am Ger-iatrSoc 1989;37:501-6.
36. Gillum RF, Folsom A, Luepker RV, et al. Sudden death and acute myocardial infarction in a metro-politan area, 1970-1980. N Engl J Med 1983;309: 1353-8.
37. Nissinen A, Kivela SL, Pekkanen J, et al. Levels of some biological risk indicators among elderly men in Finland. Age Ageing 1986;15:203-11.
38. Leren P. Prevention of coronary heart disease: some results from the Oslo secondary and primary intervention studies. J Am Coll Nutr 1989;8: 407-10.
39. Stem MP. The recent decline in ischaemic heart disease mortality. Ann Intern Med 1979;9I: 630-40.
40. National Nutrition Council of Norway. A summary of the development of the Norwegian diet. Oslo, Norway: National Nutrition Council of Norway, 1990.
41. Masironi R, Rothwell K. Trends in and effects of smoking in the world. World Health Stat Q 1988; 41:228-41.
42. Pierce JP. International comparisons of trends in cigarette smoking prevalence. Am J Public Health 1989;79:152-7.
43. Epstein FH. The relationship of lifestyle to inter-national trends in CHD. Int J Epidemiol 1989; 18(suppl. 1):S203-9.
44. Lund KE. Tobakkens pris. (Norwegian). Oslo, Nor-way: National Council on Smoking and Health, 1989.
45. Keil U. Prevention of classical risk factors. A public health and health policy task. Arzneimittelfor-schung 1990;40:388-94.
46. Dzau UJ. Atherosclerosis and hypertension: mech-anisms and interrelationships. J Cardiovasc Phar-macol 1990;15(suppl. 5):59-64.
47. Waaler HT, Hjort PF. Anti-hypertensive drugs. In: Sakshaug S, Andrew M, Hjort PF, et al., eds. Drug utilization in Norway during the 1970’s-increases, inequalities, innovations. Oslo, Norway: Norwe-gian Medicinal Depot, 1983:119-31.
48. Leren P. Lipid effects of antihypertensive drugs. Clin Exp Hypertens 1990;12:761-8.
49. National Health Screening Service, Norway. Haandbok for hjerte-kar undersoekelsen 1987. (Norwegian). Oslo, Norway: National Health Screening Service of Norway, 1987:37-9.
50. Øydvin K, ed. Legemiddelforbruket i Norge 1984-1988. Oslo, Norway: Norwegian Medicinal Depot, 1989:56-61.